Koers Mera Pharmaceuticals, Inc. Other OTC
Aandelen
MRPI
US58732R1032
Biotechnologie & Medisch Onderzoek
Omzet 2010 | 289K 270K | Omzet 2011 | 303K 283K | Marktkapitalisatie | 1,1 mln. 1,02 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2010 | - 0 | Nettowinst (verlies) 2011 | - 0 | EV/omzet 2010 | 5,85 x |
Nettoschuld 2010 | 46K 43,02K | Nettoschuld 2011 | 295K 276K | EV/omzet 2011 | 4,59 x |
K/w-verhouding 2010 |
-2,88
x | K/w-verhouding 2011 |
-4,98
x | Werknemers | - |
Dividendrendement 2010 * |
-
| Dividendrendement 2011 |
-
| Vrij verhandelbaar | 99,91% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Benny Doro
PSD | President | 57 | 17-03-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Benny Doro
PSD | President | 57 | 17-03-21 |
Rafi Markarian
BRD | Director/Board Member | 60 | 17-03-21 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+1,51% | 42,75 mld. | |
+49,22% | 41,61 mld. | |
+8,57% | 41,34 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
-25,13% | 18,12 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. |